Privia Health Group Overview
Privia Health Group Target Price
Analysts' 12-month price predictions for PRVA.
Share Price
$25.02
Average Target Price
$31.25
24.9% upside
24.9% upside4 analysts in the last 4 months
High: $40 | Low: $26
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-15 | Robert W. BairdMichael Ha | $26 | 3.9% upside |  |
| 2025-02-28 | JMP Securities | $29 | 15.9% upside | |
| 2025-02-28 | Piper Sandler | $40 | 59.9% upside | |
| 2025-02-28 | Canaccord Genuity | $30 | 19.9% upside | |
| 2025-01-10 | NeedhamMatthew Shea | $25 |  0.1% downside | |
| 2024-08-26 | Robert W. BairdMichael Ha | $24 | 4.1% downside | |
| 2024-08-08 | Evercore ISIElizabeth Anderson | $22 | 12.1% downside | |
| 2024-05-20 | BarclaysAndrew Mok | $19 | 24.1% downside | |
| 2024-05-15 | Truist FinancialJailendra Singh | $24 | 4.1% downside | |
| 2022-12-08 | UBS | $30 | 19.9% upside | |
| 2022-11-17 | Canaccord GenuityCanaccord Canaccord | $43 | 71.9% upside | |
| 2022-11-11 | Leerink Partners | $39 | 55.9% upside | |
| 2022-08-25 | Canaccord Genuity | $50 | 99.8% upside | |
| 2022-08-12 | GuggenheimSandy Draper | $51 | 103.8% upside | |
| 2022-08-12 | Truist Financial | $48 | 91.8% upside | |
| 2022-08-12 | Credit Suisse | $41 | 63.9% upside | |
| 2022-08-12 | Cowen & Co. | $44 | 75.9% upside | |
| 2022-08-12 | Leerink Partners | $46 | 83.9% upside | |
| 2022-07-25 | Truist FinancialDavid MacDonald | $40 | 59.9% upside | |
| 2022-05-13 | Canaccord Genuity | $29 | 15.9% upside | |
| 2022-04-28 | BTIG | $35 | 39.9% upside | |